查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417202

瘢痕疙瘩治療市場報告：2030 年趨勢、預測與競爭分析

Keloid Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

瘢痕疙瘩治療的趨勢和預測

預計到 2030 年，全球瘢痕疙瘩治療市場將達到約 44.3 億美元，2024 年至 2030 年年複合成長率為 3.0%。該市場的主要驅動力是燒燙傷和機動車事故的增加、瘢痕疙瘩治療方法的發展以及對整容手術的接受度不斷提高。全球瘢痕疙瘩治療市場的未來看起來充滿希望，醫院、皮膚科診所和門診手術中心（ASCS）市場充滿機會。

瘢痕疙瘩治療市場洞察

Lucintel 預計病灶內皮質類固醇注射將在預測期內達到最高成長。

預計北美地區在預測期內將出現最高的成長。

常問問題

Q.1瘢痕疙瘩治療的市場規模有多大？

A1. 到 2030 年，全球瘢痕疙瘩治療市場預計將達到 44.3 億美元。

Q.2瘢痕疙瘩治療市場的成長預測是多少？

A2. 2024年至2030年，全球瘢痕疙瘩治療市場預計將以3.0%的年複合成長率成長。

Q.3 影響瘢痕疙瘩治療市場成長的關鍵因素有哪些：

A3. 該市場的主要驅動力是燒燙傷和機動車事故的增加、瘢痕疙瘩治療方法的發展以及整容手術的接受度不斷提高。

Q4.市場的主要細分市場是：

A4.瘢痕疙瘩治療市場的前景看好，醫院、皮膚科診所和門診手術中心（ASCS）市場都有機會。

Q5.市場的主要企業是：

A5. 主要的瘢痕疙瘩治療公司如下。

  • Novartis
  • Sensus Healthcare
  • RXi Pharmaceuticals
  • Sonoma Pharmaceuticals
  • Perrigo Company
  • Bristol-Myers Squibb Company
  • Pacific World Corporation
  • Valeant Pharmaceuticals International
  • Revitol Corporation
  • Avita Medical Limited

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計病灶內皮質類固醇注射將在預測期內出現最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 預計北美在預測期內將經歷最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球瘢痕疙瘩治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球瘢痕疙瘩治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按治療分類的全球瘢痕疙瘩治療市場
    • 閉塞繃帶
    • 壓迫療法
    • 冷凍手術
    • 切除
    • 放射治療
    • 雷射治療
    • 干擾素治療
    • 病灶內注射皮質類固醇
    • 其他
  • 按最終用途行業分類的全球瘢痕疙瘩治療市場
    • 醫院
    • 皮膚科診所
    • 日間手術中心 (ASC)
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球瘢痕疙瘩治療市場（按地區）
  • 北美瘢痕疙瘩治療市場
  • 歐洲瘢痕疙瘩治療市場
  • 亞太地區瘢痕疙瘩治療市場
  • 其他地區瘢痕疙瘩治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球瘢痕疙瘩治療市場按治療方式的成長機會
    • 全球瘢痕疙瘩治療市場最終用途產業的成長機會
    • 按地區分類的全球瘢痕疙瘩治療市場成長機會
  • 全球瘢痕疙瘩治療市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球瘢痕疙瘩治療市場的產能
    • 全球瘢痕疙瘩治療市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Novartis
  • Sensus Healthcare
  • RXi Pharmaceuticals
  • Sonoma Pharmaceuticals
  • Perrigo Company
  • Bristol-Myers Squibb Company
  • Pacific World Corporation
  • Valeant Pharmaceuticals International
  • Revitol Corporation
  • Avita Medical Limited
簡介目錄

Keloid Treatment Trends and Forecast

The future of the global keloid treatment market looks promising with opportunities in the hospitals, dermatology clinics, and ambulatory surgical centers (ASCS) markets. The global keloid treatment market is expected to reach an estimated $4.43 billion by 2030 with a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are rise in burn cases and auto accidents, developments in keloid treatment methods, and growing acceptance of cosmetic surgery.

A more than 150-page report is developed to help in your business decisions.

Keloid Treatment by Segment

The study includes a forecast for the global keloid treatment by treatment, end use industry, and region.

Keloid Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Occlusive Dressing
  • Compression Therapy
  • Cryosurgery
  • Excision
  • Radiation Therapy
  • Laser Therapy
  • Interferon Therapy
  • Intralesional Corticosteroid Injections
  • Others

Keloid Treatment Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Dermatology Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

Keloid Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Keloid Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies keloid treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the keloid treatment companies profiled in this report include-

  • Novartis
  • Sensus Healthcare
  • Rxi Pharmaceuticals
  • Sonoma Pharmaceuticals
  • Perrigo Company
  • Bristol-Myers Squibb Company
  • Pacific World Corporation
  • Valeant Pharmaceuticals International
  • Revitol Corporation
  • Avita Medical Limited

Keloid Treatment Market Insights

Lucintel forecasts that intralesional corticosteroid injections is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Keloid Treatment Market

Market Size Estimates: Keloid treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Keloid treatment market size by treatment, end use industry, and region in terms of value ($B).

Regional Analysis: Keloid treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment, end use industry, and regions for the keloid treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the keloid treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the keloid treatment market size?

Answer: The global keloid treatment market is expected to reach an estimated $4.43 billion by 2030.

Q.2 What is the growth forecast for keloid treatment market?

Answer: The global keloid treatment market is expected to grow with a CAGR of 3.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the keloid treatment market?

Answer: The major drivers for this market are rise in burn cases and auto accidents, developments in keloid treatment methods, and growing acceptance of cosmetic surgery.

Q4. What are the major segments for keloid treatment market?

Answer: The future of the keloid treatment market looks promising with opportunities in the hospitals, dermatology clinics, and ambulatory surgical centers (ASCS) markets.

Q5. Who are the key keloid treatment market companies?

Answer: Some of the key keloid treatment companies are as follows.

  • Novartis
  • Sensus Healthcare
  • RXi Pharmaceuticals
  • Sonoma Pharmaceuticals
  • Perrigo Company
  • Bristol-Myers Squibb Company
  • Pacific World Corporation
  • Valeant Pharmaceuticals International
  • Revitol Corporation
  • Avita Medical Limited

Q6. Which keloid treatment market segment will be the largest in future?

Answer: Lucintel forecasts that intralesional corticosteroid injections is expected to witness highest growth over the forecast period.

Q7. In keloid treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the keloid treatment market by treatment (occlusive dressing, compression therapy, cryosurgery,excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injections, and others, ), end use industry (hospitals, dermatology clinics, ambulatory surgical centers (ASCS), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Keloid Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Keloid Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Keloid Treatment Market by Treatment
    • 3.3.1: Occlusive Dressing
    • 3.3.2: Compression Therapy
    • 3.3.3: Cryosurgery
    • 3.3.4: Excision
    • 3.3.5: Radiation Therapy
    • 3.3.6: Laser Therapy
    • 3.3.7: Interferon Therapy
    • 3.3.8: Intralesional Corticosteroid Injections
    • 3.3.9: Others
  • 3.4: Global Keloid Treatment Market by End Use Industry
    • 3.4.1: Hospitals
    • 3.4.2: Dermatology Clinics
    • 3.4.3: Ambulatory Surgical Centers (ASCs)
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Keloid Treatment Market by Region
  • 4.2: North American Keloid Treatment Market
    • 4.2.2: North American Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others
  • 4.3: European Keloid Treatment Market
    • 4.3.1: European Keloid Treatment Market by Treatment: Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, and Others
    • 4.3.2: European Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others
  • 4.4: APAC Keloid Treatment Market
    • 4.4.1: APAC Keloid Treatment Market by Treatment: Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, and Others
    • 4.4.2: APAC Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others
  • 4.5: ROW Keloid Treatment Market
    • 4.5.1: ROW Keloid Treatment Market by Treatment: Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, and Others
    • 4.5.2: ROW Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Keloid Treatment Market by Treatment
    • 6.1.2: Growth Opportunities for the Global Keloid Treatment Market by End Use Industry
    • 6.1.3: Growth Opportunities for the Global Keloid Treatment Market by Region
  • 6.2: Emerging Trends in the Global Keloid Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Keloid Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Keloid Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Novartis
  • 7.2: Sensus Healthcare
  • 7.3: RXi Pharmaceuticals
  • 7.4: Sonoma Pharmaceuticals
  • 7.5: Perrigo Company
  • 7.6: Bristol-Myers Squibb Company
  • 7.7: Pacific World Corporation
  • 7.8: Valeant Pharmaceuticals International
  • 7.9: Revitol Corporation
  • 7.10: Avita Medical Limited